Freenome

Freenome is a biotech company that develops advanced blood tests to detect cancer early, often before symptoms appear. Using cutting-edge algorithms and machine learning, they analyze fragments of DNA and other molecules in the blood to identify signs of cancer with high accuracy. This approach aims to enable earlier diagnosis, improve treatment outcomes, and potentially reduce the need for invasive biopsies. Freenome’s technology is part of a broader movement towards personalized, non-invasive healthcare, offering a promising way to catch cancers sooner and improve patient care through early intervention.